Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heritable Pulmonary Arterial Hypertension”

984 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 984 results

Not applicableStudy completedNCT01266265
What this trial is testing

Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 1,333
Not applicableStudy completedNCT03888365
What this trial is testing

Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 43
Not applicableLooking for participantsNCT06499363
What this trial is testing

Treprostinil in Newborns With Pulmonary Hypertension; a Non-Interventional Study to Collect Data on Drug Utilization, Safety, and Effectiveness

Who this might be right for
Persistent Pulmonary Hypertension of Newborn
Ferrer Internacional S.A. 60
Testing effectiveness (Phase 2)Study completedNCT00990314
What this trial is testing

Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients

Who this might be right for
Pulmonary Arterial Hypertension
Lung Biotechnology PBC 31
Large-scale testing (Phase 3)WithdrawnNCT02999906
What this trial is testing

Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics
Post-approval studies (Phase 4)Study completedNCT01800292
What this trial is testing

Characterization of LV Strain Patterns in Mildly Elevated PCWP and PAH.

Who this might be right for
Hypertension, Pulmonary ArteryVentricular Dysfunction, Left
University of Arizona 9
Not applicableStudy completedNCT04094272
What this trial is testing

Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection

Who this might be right for
Pulmonary Artery HypertensionChronic Hepatitis c
Kantonsspital Olten 49
Not applicableStudy completedNCT01516398
What this trial is testing

Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia

Who this might be right for
Bronchopulmonary Dysplasia (BPD)Hypertension, Pulmonary
Stanford University 40
Not applicableUnknownNCT03841344
What this trial is testing

Repeatability and Sensitivity to Change of Non-invasive Endpoints in PAH

Who this might be right for
Pulmonary Arterial Hypertension
University of Sheffield 44
Early research (Phase 1)Study completedNCT04991181
What this trial is testing

Absorption, Distribution, Metabolism and Excretion of BIA 5-1058

Who this might be right for
Pulmonary Arterial Hypertension
Bial - Portela C S.A. 15
Very early researchEnded earlyNCT02748798
What this trial is testing

Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders

Who this might be right for
Lung TransplantLung ResectionLung Cancer+16 more
Thunder Bay Regional Health Research Institute 10
Not applicableEnrolling By InvitationNCT06041906
What this trial is testing

International Registry of Congenital Portosystemic Shunt (IRCPSS)

Who this might be right for
Congenital Portosystemic ShuntCPSS (Congenital Portosystemic Shunt)
Prof. Valérie Mc Lin 500
Not applicableStudy completedNCT02371733
What this trial is testing

Aerobic Exercise Training in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Gazi University 30
Not applicableStudy completedNCT01959815
What this trial is testing

Novel Screening Strategies for Scleroderma PAH

Who this might be right for
Pulmonary Arterial HypertensionScleroderma
University of Michigan 156
Not applicableLooking for participantsNCT01501838
What this trial is testing

Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos Aires

Who this might be right for
Hypertension, Pulmonary Arterial
Hospital Italiano de Buenos Aires 200
Not applicableStudy completedNCT05124015
What this trial is testing

Exercise Capacity Respiratory Muscle Strength Dyspnea and Physical Activity in Pediatric Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Gazi University 33
Not applicableStudy completedNCT01721564
What this trial is testing

Bosentan and Pulmonary Endothelial Function

Who this might be right for
Pulmonary Arterial Hypertension
Prof David S Celermajer 8
Not applicableStudy completedNCT06907693
What this trial is testing

The Effects of Drug Candidate CS1 on Lung Structure and Function Utilizing FRI

Who this might be right for
Pulmonary Arterial Hypertension
Prisma Health-Upstate 7
Early research (Phase 1)Looking for participantsNCT05967299
What this trial is testing

Study of Intravenous ZMA001 in Healthy Subjects

Who this might be right for
Pulmonary Arterial Hypertension PAH
National Heart, Lung, and Blood Institute (NHLBI) 96
Not applicableStudy completedNCT02826252
What this trial is testing

Examination of Ventavis (Iloprost) Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20)

Who this might be right for
Hypertension, Pulmonary
Bayer 64
Load More Results